"Bladder Cancer: Be Active In Your Treatment And Self-Care"
In 2017, it’s estimated that there will be about 79,000 new cases of bladder cancer in the United States, adding to the many thousands already battling the disease. To ensure the best outcome for every patient, the American Society of Clinical oncology suggests a team-based approach that includes patients taking an active role in treatment decisions. However, bladder cancer patients have an enormous amount to learn, from the biology of the disease and how doctors diagnose it to current treatments, surgical options and possible lifestyle changes. The comprehensive education program was developed by bladder cancer specialists from the Mount Sinai Hospital, including Matthew Galsky, MD, professor of urology, medicine, hematology and medical oncology, and director of genitourinary medical oncology at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai and Nihal Mohamed, PhD, assistant professor of urology at the Icahn School of Medicine at Mount Sinai.
- Matthew Galsky, MD, Director of the Novel Therapeutics Program, Clinical Trials Program and Genitourinary Medical Oncology at The Tisch Cancer Institute at Mount Sinai and Professor of Urology, Medicine, Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai.
- Nihal Mohamed, PhD, Assistant Professor, Urology, Icahn School of Medicine at Mount Sinai
Immunotherapy After Bladder Cancer Surgery Shows Excellent Cancer-free Survival Rates
May 14, 2022 View All Press Releases"Dr. Galsky Discusses Combination Immunotherapy In Bladder Cancer"
Jun 29, 2018 View All Press Releases